April 12, 2018

CELGENE CORPORATION v. DR. REDDY'S LABORATORIES, LTD. et al

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. April 13, 2018

    Celgene Sues To Block Dr. Reddy's Revlimid Generic

    Celgene Corp. on Thursday tried to block Dr. Reddy's Laboratories Ltd. from making and selling a generic version of its blockbuster chemotherapy drug Revlimid, accusing the Indian drugmaker in New Jersey federal court of infringing five patents.


Parties

To view the parties, register now.